Standard
In-utero exposure to tenofovir is associated with impaired fetal and infant growth : need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants. / Denneman, Lisanne; Cohen, Sophie; Godfried, Mieke H; van Leeuwen, Elisabeth; Nellen, Jeannine F B; Kuijpers, Taco W; Pajkrt, Dasja; van de Plas, Atie; Smit, Colette; Weijsenfeld, Anouschka M; Scherpbier, Henriette J; Bunders, Madeleine J.
In:
AIDS, Vol. 30, No. 13, 24.08.2016, p. 2135-2137.
Research output: SCORING: Contribution to journal › Letter › Research › peer-review
Harvard
Denneman, L, Cohen, S, Godfried, MH, van Leeuwen, E, Nellen, JFB, Kuijpers, TW, Pajkrt, D, van de Plas, A, Smit, C, Weijsenfeld, AM, Scherpbier, HJ
& Bunders, MJ 2016, '
In-utero exposure to tenofovir is associated with impaired fetal and infant growth: need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants',
AIDS, vol. 30, no. 13, pp. 2135-2137.
https://doi.org/10.1097/QAD.0000000000001156APA
Denneman, L., Cohen, S., Godfried, M. H., van Leeuwen, E., Nellen, J. F. B., Kuijpers, T. W., Pajkrt, D., van de Plas, A., Smit, C., Weijsenfeld, A. M., Scherpbier, H. J.
, & Bunders, M. J. (2016).
In-utero exposure to tenofovir is associated with impaired fetal and infant growth: need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants.
AIDS,
30(13), 2135-2137.
https://doi.org/10.1097/QAD.0000000000001156Vancouver
Bibtex
@article{5432417f3e2f424ab94dfa3aafdb16b7,
title = "In-utero exposure to tenofovir is associated with impaired fetal and infant growth: need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants",
keywords = "Anti-HIV Agents/administration & dosage, Birth Weight/drug effects, Child Development/drug effects, Female, Fetal Development/drug effects, Fetal Growth Retardation/chemically induced, Follow-Up Studies, Growth Disorders/chemically induced, HIV Infections/drug therapy, Humans, Infant, Infectious Disease Transmission, Vertical/prevention & control, Pregnancy, Pregnancy Complications, Infectious/drug therapy, Prenatal Exposure Delayed Effects/chemically induced, Retrospective Studies, Tenofovir/administration & dosage",
author = "Lisanne Denneman and Sophie Cohen and Godfried, {Mieke H} and {van Leeuwen}, Elisabeth and Nellen, {Jeannine F B} and Kuijpers, {Taco W} and Dasja Pajkrt and {van de Plas}, Atie and Colette Smit and Weijsenfeld, {Anouschka M} and Scherpbier, {Henriette J} and Bunders, {Madeleine J}",
year = "2016",
month = aug,
day = "24",
doi = "10.1097/QAD.0000000000001156",
language = "English",
volume = "30",
pages = "2135--2137",
journal = "AIDS",
issn = "0269-9370",
publisher = "Lippincott Williams and Wilkins",
number = "13",
}
RIS
TY - JOUR
T1 - In-utero exposure to tenofovir is associated with impaired fetal and infant growth
T2 - need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants
AU - Denneman, Lisanne
AU - Cohen, Sophie
AU - Godfried, Mieke H
AU - van Leeuwen, Elisabeth
AU - Nellen, Jeannine F B
AU - Kuijpers, Taco W
AU - Pajkrt, Dasja
AU - van de Plas, Atie
AU - Smit, Colette
AU - Weijsenfeld, Anouschka M
AU - Scherpbier, Henriette J
AU - Bunders, Madeleine J
PY - 2016/8/24
Y1 - 2016/8/24
KW - Anti-HIV Agents/administration & dosage
KW - Birth Weight/drug effects
KW - Child Development/drug effects
KW - Female
KW - Fetal Development/drug effects
KW - Fetal Growth Retardation/chemically induced
KW - Follow-Up Studies
KW - Growth Disorders/chemically induced
KW - HIV Infections/drug therapy
KW - Humans
KW - Infant
KW - Infectious Disease Transmission, Vertical/prevention & control
KW - Pregnancy
KW - Pregnancy Complications, Infectious/drug therapy
KW - Prenatal Exposure Delayed Effects/chemically induced
KW - Retrospective Studies
KW - Tenofovir/administration & dosage
U2 - 10.1097/QAD.0000000000001156
DO - 10.1097/QAD.0000000000001156
M3 - Letter
C2 - 27465280
VL - 30
SP - 2135
EP - 2137
JO - AIDS
JF - AIDS
SN - 0269-9370
IS - 13
ER -
